Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
Status:
Completed
Trial end date:
2006-11-08
Target enrollment:
Participant gender:
Summary
Valproic acid is a medication that is currently used in the prevention of seizures, bipolar
disorder, and migraine headaches. Researchers hope that it may improve the effects of
decitabine. Decitabine is a chemotherapy drug with known activity in leukemia and
myelodysplastic syndromes.